Tech Company Financing Transactions

Ona Therapeutics Funding Round

Columbus Venture Partners, Mérieux Equity Partners and Alta Life Sciences participated in a $86.6 million Series B funding round for Ona Therapeutics. The round was announced on 6/4/2026.

Transaction Overview

Company Name
Announced On
6/4/2026
Transaction Type
Venture Equity
Amount
$86,600,000
Round
Series B
Proceeds Purpose
The company intends to use the funds to advance the clinical development of its lead program, ONA-255, an ADC initially focused on breast cancer, and to progress ONA-389, a second ADC targeting colorectal cancer.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
PCB, Parc Científic de Barcelona,? Carrer de Baldiri Reixac,
Barcelona, 08028
Spain
Phone
Undisclosed
Email Address
Overview
Ona Therapeutics is a biotechnology company spun out of ICREA and IRB, specializing in unravelling novel biology to design biotherapeutics for advanced cancers. Following the assembly of a multinational team of experienced biotech executives, Ona Therapeutics has maintained its focus on two wholly owned internal programs. Our lead program is an undisclosed first-in-class antibody drug conjugate that is being initially developed for a specific population of refractory breast cancer patients. We are also developing a monoclonal antibody against CD36, a metabolic regulator of fatty acid transport that has been implicated in multiple aspects of cancer progression.
Profile
Ona Therapeutics LinkedIn Company Profile
Social Media
Ona Therapeutics Company Twitter Account
Company News
Ona Therapeutics News
Facebook
Ona Therapeutics on Facebook
YouTube
Ona Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Valerie Vanhooren
  Valerie Vanhooren LinkedIn Profile  Valerie Vanhooren Twitter Account  Valerie Vanhooren News  Valerie Vanhooren on Facebook
Chief Financial Officer
Julià Mesquida
  Julià Mesquida LinkedIn Profile  Julià Mesquida Twitter Account  Julià Mesquida News  Julià Mesquida on Facebook
Chief Medical Officer
Jutta Amersdorffer
  Jutta Amersdorffer LinkedIn Profile  Jutta Amersdorffer Twitter Account  Jutta Amersdorffer News  Jutta Amersdorffer on Facebook
Chief Operating Officer
Mercè de Frias
  Mercè de Frias LinkedIn Profile  Mercè de Frias Twitter Account  Mercè de Frias News  Mercè de Frias on Facebook
Chief Scientific Officer
Haijun Sun
  Haijun Sun LinkedIn Profile  Haijun Sun Twitter Account  Haijun Sun News  Haijun Sun on Facebook
VP - R & D
Beatriz Morancho
  Beatriz Morancho LinkedIn Profile  Beatriz Morancho Twitter Account  Beatriz Morancho News  Beatriz Morancho on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/4/2026: Lassie venture capital transaction
Next: 6/4/2026: Willow venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary